Itrasave Cream is a topical formulation combining Ofloxacin (0.75% w/w), Ornidazole (2.0% w/w), Itraconazole (1.0% w/w), and Clobetasol (0.05% w/w), designed for the effective management of mixed bacterial, protozoal, and fungal infections accompanied by inflammatory skin conditions. Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, targets gram-positive and gram-negative bacteria by inhibiting DNA gyrase, thereby preventing bacterial replication. Ornidazole, a nitroimidazole derivative, exhibits potent antiprotozoal and antibacterial activity, particularly against anaerobic organisms, by disrupting DNA synthesis. Itraconazole, a triazole antifungal agent, impedes ergosterol synthesis, essential for fungal cell membrane integrity, effectively treating dermatophytic and yeast infections. Clobetasol propionate, a potent corticosteroid, provides anti-inflammatory, antipruritic, and vasoconstrictive effects, reducing erythema, swelling, and discomfort associated with dermatological conditions. The synergistic combination in Itrasave Cream ensures comprehensive treatment of polymicrobial infections with inflammatory manifestations such as dermatitis, eczema, and mixed infections resistant to monotherapy. It is indicated for use under medical supervision to minimize potential adverse effects, including skin atrophy and systemic absorption risks associated with corticosteroids. Patients should adhere strictly to prescribed usage guidelines and avoid prolonged application to prevent complications. Itrasave Cream offers an integrated therapeutic approach for complex cutaneous infections requiring antibacterial, antifungal, antiprotozoal, and anti-inflammatory intervention.